Skip to main content
Top
Published in: Urolithiasis 2/2012

01-04-2012 | Original Paper

Role of osteopontin in early phase of renal crystal formation: immunohistochemical and microstructural comparisons with osteopontin knock-out mice

Authors: Masahito Hirose, Keiichi Tozawa, Atsushi Okada, Shuzo Hamamoto, Yuji Higashibata, Bin Gao, Yutaro Hayashi, Hideo Shimizu, Yasue Kubota, Takahiro Yasui, Kenjiro Kohri

Published in: Urolithiasis | Issue 2/2012

Login to get access

Abstract

Osteopontin (OPN) is an important matrix protein of renal calcium stone. However, the function of OPN in the early phase of renal crystal formation is not well defined. In this study, we examined OPN expression in the early phase of renal crystal formation with ultra-microstructural observations and immuno-TEM (transmission electron microscopy) in control and OPN knock-out (OPN-KO) mice. Glyoxylate (100 mg/kg) was intra-abdominally administered to male wild-type mice (C57BL/6, 8 weeks of age) and OPN-KO mice (C57BL/6, 8 weeks of age). Kidney was collected before and 6, 12, and 24 h after administration. We examined the relation between renal crystal formation and microstructural OPN location using TEM and immunohistochemical staining of OPN as well as western blotting and quantitative RT-PCR for OPN. OPN protein expression gradually increased in the renal cortex-medulla junction after glyoxylate administration, and OPN mRNA was increased until 12 h, but decreased at 24 h. In ultra-microstructural observation, OPN began to appear on the luminal side of renal distal tubular cells at 6 h and was gradually detected in the tubular lumen at 12 h. OPN was present in the crystal nuclei and collapsed mitochondria in the tubular lumen. In the OPN-KO mice, collapsed mitochondria were present, but no crystal nuclei formation were detected at 24 h. Based on the results this study proposed that the appearance of organelles, such as mitochondria and microvilli, in the tubular lumen after cell injury may be the starting point of crystal nucleus formation due to the aggregation ability of OPN.
Literature
1.
go back to reference Kulaksizoglu S, Sofikerim M, Cevik C (2007) Impact of various modifiers on calcium oxalate crystallization. Int J Urol 14:214–218PubMedCrossRef Kulaksizoglu S, Sofikerim M, Cevik C (2007) Impact of various modifiers on calcium oxalate crystallization. Int J Urol 14:214–218PubMedCrossRef
2.
go back to reference Mo L, Liaw L, Evan AP et al (2007) Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both. Am J Physiol Renal Physiol 293:1935–1943CrossRef Mo L, Liaw L, Evan AP et al (2007) Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both. Am J Physiol Renal Physiol 293:1935–1943CrossRef
3.
go back to reference Khan SR (2004) Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 8:75–88PubMedCrossRef Khan SR (2004) Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin Exp Nephrol 8:75–88PubMedCrossRef
4.
go back to reference Canales BK, Anderson L, Higgins L et al (2008) Second prize: comprehensive proteomic analysis of human calcium oxalate monohydrate kidney stone matrix. J Endourol 22:1161–1167PubMedCrossRef Canales BK, Anderson L, Higgins L et al (2008) Second prize: comprehensive proteomic analysis of human calcium oxalate monohydrate kidney stone matrix. J Endourol 22:1161–1167PubMedCrossRef
5.
go back to reference Merchant ML, Cummins TD, Wilkey DW et al (2008) Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation. Am J Physiol Renal Physiol 295:F1254–F1258PubMedCrossRef Merchant ML, Cummins TD, Wilkey DW et al (2008) Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation. Am J Physiol Renal Physiol 295:F1254–F1258PubMedCrossRef
6.
go back to reference Kohri K, Suzuki Y, Yoshida K et al (1992) Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin. Biochem Biophys Res Commun 184:859–864PubMedCrossRef Kohri K, Suzuki Y, Yoshida K et al (1992) Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin. Biochem Biophys Res Commun 184:859–864PubMedCrossRef
7.
go back to reference O’Brien ER, Garvin MR, Stewart DK et al (1994) Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb 14:1648–1656PubMedCrossRef O’Brien ER, Garvin MR, Stewart DK et al (1994) Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb 14:1648–1656PubMedCrossRef
8.
go back to reference Giachelli CM, Lombardi D, Johnson RJ et al (1998) Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152:353–358PubMed Giachelli CM, Lombardi D, Johnson RJ et al (1998) Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152:353–358PubMed
9.
go back to reference Liaw L, Birk DE, Ballas CB et al (1998) Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest 101:1468–1478PubMed Liaw L, Birk DE, Ballas CB et al (1998) Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest 101:1468–1478PubMed
10.
go back to reference Ophascharoensuk V, Giachelli CM, Gordon K et al (1999) Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56:571–580PubMedCrossRef Ophascharoensuk V, Giachelli CM, Gordon K et al (1999) Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56:571–580PubMedCrossRef
11.
go back to reference Scatena M, Almeida M, Chaisson ML et al (1998) NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. J Cell Biol 141:1083–1093PubMedCrossRef Scatena M, Almeida M, Chaisson ML et al (1998) NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. J Cell Biol 141:1083–1093PubMedCrossRef
12.
go back to reference Brown LF, Berse B, Van de Water L et al (1992) Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Biol Cell 3:1169–1180PubMed Brown LF, Berse B, Van de Water L et al (1992) Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Biol Cell 3:1169–1180PubMed
13.
go back to reference Kleinman JG, Beshensky A, Worcester EM et al (1995) Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney. Kidney Int 47:1585–1596PubMedCrossRef Kleinman JG, Beshensky A, Worcester EM et al (1995) Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney. Kidney Int 47:1585–1596PubMedCrossRef
14.
go back to reference Itoh Y, Yasui T, Okada A et al (2005) Examination of the anti-oxidative effect in renal tubular cells and apoptosis by oxidative stress. Urol Res 33:261–266PubMedCrossRef Itoh Y, Yasui T, Okada A et al (2005) Examination of the anti-oxidative effect in renal tubular cells and apoptosis by oxidative stress. Urol Res 33:261–266PubMedCrossRef
15.
go back to reference Kohri K, Nomura S, Kitamura Y et al (1993) Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 268:15180–15184PubMed Kohri K, Nomura S, Kitamura Y et al (1993) Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 268:15180–15184PubMed
16.
go back to reference Pampena DA, Robertson KA, Litvinova O et al (2004) Inhibition of hydroxyapatite formation by osteopontin phosphopeptides. Biochem J 378:1083–1087PubMedCrossRef Pampena DA, Robertson KA, Litvinova O et al (2004) Inhibition of hydroxyapatite formation by osteopontin phosphopeptides. Biochem J 378:1083–1087PubMedCrossRef
17.
go back to reference O’Brien KD, Kuusisto J, Reichenbach DD et al (1995) Osteopontin is expressed in human aortic valvular lesions. Circulation 92:2163–2168PubMed O’Brien KD, Kuusisto J, Reichenbach DD et al (1995) Osteopontin is expressed in human aortic valvular lesions. Circulation 92:2163–2168PubMed
18.
go back to reference Srivatsa SS, Harrity PJ, Maercklein PB et al (1997) Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves. J Clin Invest 99:996–1009PubMedCrossRef Srivatsa SS, Harrity PJ, Maercklein PB et al (1997) Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves. J Clin Invest 99:996–1009PubMedCrossRef
19.
go back to reference Ikeda T, Shirasawa T, Esaki Y et al (1993) Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest 92:2814–2820PubMedCrossRef Ikeda T, Shirasawa T, Esaki Y et al (1993) Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest 92:2814–2820PubMedCrossRef
20.
go back to reference Wada T, McKee MD, Steitz S et al (1999) Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ Res 84:166–178PubMed Wada T, McKee MD, Steitz S et al (1999) Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ Res 84:166–178PubMed
21.
go back to reference Kleinman JG, Beshensky A, Worcester EM et al (1995) Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney. Kidney Int 47:1585–1596PubMedCrossRef Kleinman JG, Beshensky A, Worcester EM et al (1995) Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney. Kidney Int 47:1585–1596PubMedCrossRef
22.
go back to reference Asplin JR, Arsenault D, Parks JH et al (1998) Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int 53:194–199PubMedCrossRef Asplin JR, Arsenault D, Parks JH et al (1998) Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int 53:194–199PubMedCrossRef
23.
go back to reference Min W, Shiraga H, Chalko C et al (1998) Quantitative studies of human urinary excretion of uropontin. Kidney Int 53:189–193PubMedCrossRef Min W, Shiraga H, Chalko C et al (1998) Quantitative studies of human urinary excretion of uropontin. Kidney Int 53:189–193PubMedCrossRef
24.
go back to reference Nishio S, Hatanaka M, Takeda H et al (2000) Calcium phosphate crystal-associated proteins: alpha2-HS-glycoprotein, prothrombin F1, and osteopontin. Mol Urol 4:383–390PubMed Nishio S, Hatanaka M, Takeda H et al (2000) Calcium phosphate crystal-associated proteins: alpha2-HS-glycoprotein, prothrombin F1, and osteopontin. Mol Urol 4:383–390PubMed
25.
go back to reference Nishio S, Hatanaka M, Takeda H et al (1999) Analysis of urinary concentrations of calcium phosphate crystal-associated proteins: alpha2-HS-glycoprotein, prothrombin F1, and osteopontin. J Am Soc Nephrol 10:394–396 Nishio S, Hatanaka M, Takeda H et al (1999) Analysis of urinary concentrations of calcium phosphate crystal-associated proteins: alpha2-HS-glycoprotein, prothrombin F1, and osteopontin. J Am Soc Nephrol 10:394–396
26.
go back to reference Yamate T, Kohri K, Umekawa T et al (1996) The effect of osteopontin on the adhesion of calcium oxalate crystals to Madin-Darby canine kidney cells. Eur Urol 30:388–393PubMed Yamate T, Kohri K, Umekawa T et al (1996) The effect of osteopontin on the adhesion of calcium oxalate crystals to Madin-Darby canine kidney cells. Eur Urol 30:388–393PubMed
27.
go back to reference Lieske JC, Leonard R, Toback FG (1995) Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am J Physiol 268:F604–F612PubMed Lieske JC, Leonard R, Toback FG (1995) Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am J Physiol 268:F604–F612PubMed
28.
go back to reference Yamate T, Kohri K, Umekawa T et al (1998) Osteopontin antisense oligonucleotide inhibits adhesion of calcium oxalate crystals in Madin-Darby canine kidney cell. J Urol 160:1506–1512PubMedCrossRef Yamate T, Kohri K, Umekawa T et al (1998) Osteopontin antisense oligonucleotide inhibits adhesion of calcium oxalate crystals in Madin-Darby canine kidney cell. J Urol 160:1506–1512PubMedCrossRef
29.
go back to reference McKee MD, Nanci A, Khan SR (1995) Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi. J Bone Miner Res 10:1913–1929PubMedCrossRef McKee MD, Nanci A, Khan SR (1995) Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi. J Bone Miner Res 10:1913–1929PubMedCrossRef
30.
go back to reference Ryall RL, Grover PK, Thurgood LA et al (2007) The importance of a clean face: the effect of different washing procedures on the association of Tamm-Horsfall glycoprotein and other urinary proteins with calcium oxalate crystals. Urol Res 35:1–14PubMedCrossRef Ryall RL, Grover PK, Thurgood LA et al (2007) The importance of a clean face: the effect of different washing procedures on the association of Tamm-Horsfall glycoprotein and other urinary proteins with calcium oxalate crystals. Urol Res 35:1–14PubMedCrossRef
31.
go back to reference Okada A, Nomura S, Saeki Y et al (2008) Morphological conversion of calcium oxalate crystals into stones is regulated by osteopontin in mouse kidney. J Bone Miner Res 23:1629–1637PubMedCrossRef Okada A, Nomura S, Saeki Y et al (2008) Morphological conversion of calcium oxalate crystals into stones is regulated by osteopontin in mouse kidney. J Bone Miner Res 23:1629–1637PubMedCrossRef
32.
go back to reference Hamamoto S, Nomura S, Yasui T et al (2009) Effects of impaired functional domains of osteopontin on renal crystal formation: analyses of OPN-transgenic and OPN-knockout mice. J Bone Miner Res 25:2712–2723PubMed Hamamoto S, Nomura S, Yasui T et al (2009) Effects of impaired functional domains of osteopontin on renal crystal formation: analyses of OPN-transgenic and OPN-knockout mice. J Bone Miner Res 25:2712–2723PubMed
33.
go back to reference Umekawa T, Yamate T, Amasaki N et al (1995) Osteopontin mRNA in the kidney on an experimental rat model of renal stone formation without renal failure. Urol Int 55:6–10PubMedCrossRef Umekawa T, Yamate T, Amasaki N et al (1995) Osteopontin mRNA in the kidney on an experimental rat model of renal stone formation without renal failure. Urol Int 55:6–10PubMedCrossRef
34.
go back to reference Umekawa T, Kohri K, Kurita T et al (1995) Expression of osteopontin messenger RNA in the rat kidney on experimental model of renal stone. Biochem Mol Biol Int 35:223–230PubMed Umekawa T, Kohri K, Kurita T et al (1995) Expression of osteopontin messenger RNA in the rat kidney on experimental model of renal stone. Biochem Mol Biol Int 35:223–230PubMed
35.
go back to reference Hoyer JR, Otvos L Jr, Urge L (1995) Osteopontin in urinary stone formation. Ann N Y Acad Sci 760:257–265PubMedCrossRef Hoyer JR, Otvos L Jr, Urge L (1995) Osteopontin in urinary stone formation. Ann N Y Acad Sci 760:257–265PubMedCrossRef
36.
go back to reference Umekawa T (1999) Structural characteristics of osteopontin for calcium oxalate crystal. Jpn J Urol 90:436–444 Umekawa T (1999) Structural characteristics of osteopontin for calcium oxalate crystal. Jpn J Urol 90:436–444
37.
go back to reference Ryall RL, Chauvet MC, Grover PK (2005) Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals. BJU Int 96:654–663PubMedCrossRef Ryall RL, Chauvet MC, Grover PK (2005) Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals. BJU Int 96:654–663PubMedCrossRef
38.
go back to reference Kleinman JG, Wesson JA, Hughes J (2004) Osteopontin and calcium stone formation. Nephron Physiol 98:43–47CrossRef Kleinman JG, Wesson JA, Hughes J (2004) Osteopontin and calcium stone formation. Nephron Physiol 98:43–47CrossRef
39.
go back to reference Evan AP, Coe FL, Rittling SR et al (2005) Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int 68:145–154PubMedCrossRef Evan AP, Coe FL, Rittling SR et al (2005) Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int 68:145–154PubMedCrossRef
40.
go back to reference Hirose M, Yasui T, Okada A et al (2009) Renal tubular epithelial cell injury and oxidative stress induce calcium oxalate crystal formation in mouse kidney. Int J Urol 17:83–92PubMedCrossRef Hirose M, Yasui T, Okada A et al (2009) Renal tubular epithelial cell injury and oxidative stress induce calcium oxalate crystal formation in mouse kidney. Int J Urol 17:83–92PubMedCrossRef
41.
go back to reference Hirose M, Tozawa K, Okada A et al (2008) Glyoxylate induces renal tubular cell injury and microstructural changes in experimental mouse. Urol Res 36:139–147PubMedCrossRef Hirose M, Tozawa K, Okada A et al (2008) Glyoxylate induces renal tubular cell injury and microstructural changes in experimental mouse. Urol Res 36:139–147PubMedCrossRef
42.
go back to reference Vernon HJ, Osborne C, Tzortzaki EG et al (2005) Aprt/Opn double knockout mice: osteopontin is a modifier of kidney stone disease severity. Kidney Int 68:938–947PubMedCrossRef Vernon HJ, Osborne C, Tzortzaki EG et al (2005) Aprt/Opn double knockout mice: osteopontin is a modifier of kidney stone disease severity. Kidney Int 68:938–947PubMedCrossRef
43.
go back to reference Nakamura I, Duong le T, Rodan SB et al (2007) Involvement of alpha(v)beta3 integrins in osteoclast function. J Bone Miner Metab 25:337–344PubMedCrossRef Nakamura I, Duong le T, Rodan SB et al (2007) Involvement of alpha(v)beta3 integrins in osteoclast function. J Bone Miner Metab 25:337–344PubMedCrossRef
Metadata
Title
Role of osteopontin in early phase of renal crystal formation: immunohistochemical and microstructural comparisons with osteopontin knock-out mice
Authors
Masahito Hirose
Keiichi Tozawa
Atsushi Okada
Shuzo Hamamoto
Yuji Higashibata
Bin Gao
Yutaro Hayashi
Hideo Shimizu
Yasue Kubota
Takahiro Yasui
Kenjiro Kohri
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 2/2012
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-011-0400-z

Other articles of this Issue 2/2012

Urolithiasis 2/2012 Go to the issue